A Review of the Oral Semaglutide in Adults with Overweight or Obesity (OASIS) Trials Evaluating Oral Semaglutide (Wegovy) for Chronic Weight Management in Adults With Overweight or Obesity.

Cureus · 2026 · PMC13220851 · PMID 42220771

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

failed to reach statistical significanceP=0.05actually significant

Nevertheless, the difference failed to reach statistical significance (treatment policy estimand; ETD, 5.30; 95% CI, -0.01 to 10.62; P=0.05).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.